Caitlyn Miller
CEO & Co-Founder TwoStep Therapeutics
Caitlyn Miller, PhD, co-founder and CEO of TwoStep Therapeutics, is dedicated to the company’s mission of bringing innovative targeted therapies to patients. Dr. Miller received her PhD in Bioengineering from Stanford University in the labs of Dr. Carolyn Bertozzi and Dr. Jennifer Cochran. During her PhD and postdoctoral work, Dr. Miller played a pivotal role in advancing technology that is now integrated into TwoStep’s therapeutic pipeline. Dr. Miller then joined the Stanford Innovative Medicines Accelerator as an Entrepreneur-In-Residence, where she spearheaded the efforts to spin out TwoStep Therapeutics.
Seminars
Wednesday 18th March 2026
Multispecific Drug Conjugates Combat Tumor Heterogeneity & Resistance
4:30 pm
- Scientific rationale for TwoStep Therapeutics’ multi-specific targeting agent “PIP” and how it enables broad applicability across solid tumors
- Preclinical development of PIP-drug conjugates, their efficacy and safety, and comparison to clinical benchmarks
- Comparing the data from a single vs multi-targeted approach to highlight the rationale of multi-specific targeting
